Revenue Growth
Q3 revenues of $761 million, up 16.7% year-over-year (organic growth ~12.6% and ~4.1% benefit from FX). Year-to-date revenue growth of 13.6% (approx. 8% organic).
Strong Profitability Improvement
Adjusted earnings from operations of $79.9–$80.0 million in Q3, up 21.6% year-over-year; adjusted EPS of $0.48 for the quarter.
Robust Order Backlog and Book-to-Bill
Order backlog of approximately $2.1 billion at quarter end and a trailing 12-month book-to-bill ratio of 1.06:1, indicating continued demand coverage.
Order Bookings Momentum (Sequential)
Order bookings in Q3 of $821 million, up almost 12% sequentially and supported by activity across multiple end markets.
Life Sciences Strength
Life Sciences backlog of $1.1 billion and Life Sciences revenue of $391 million in Q3 (the second-highest in ATS history); continued momentum in radiopharma and GLP-1 auto-injector programs.
Energy Segment Acceleration
Energy order backlog reached a record $296 million in Q3, up 87% versus Q3 last year, driven by nuclear refurbishment and life-extension projects as well as participation in new-build reactor work including SMRs.
Consumer & Food & Beverage Backlog Highlights
Consumer Products backlog a record $321 million (driven by a large enterprise warehouse packaging program); Food & Beverage backlog $203 million with a strong funnel in core processing markets.
Cash Generation and Working Capital Progress
Operating cash flow of $115 million in Q3; non-cash working capital at 16.4% of revenues, an improvement sequentially and toward the stated target of less than 15%.
Capital Allocation & Balance Sheet Discipline
Q3 CapEx and intangibles of $16.6 million; fiscal '26 CapEx and intangible guidance narrowed/downward to $70–$90 million; net debt to adjusted EBITDA ~3x, signaling progress toward leverage target range of 2–3x and disciplined approach to M&A and reinvestment.
Strategic & Organizational Moves
New CEO appointed (Doug Wright) with focus on lean/ABM execution and margin expansion; key leadership additions (Sarah Moore for Life Sciences, Simon Roberts for Packaging & Food); services integrated into operating units to drive recurring, margin-enhancing aftermarket revenue.